Fractionated stereotactic conformal radiotherapy in the management of large chemodectomas of the skull base

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 5, 2004, Pages 1445-1450

  Zabel, Angelika ^a,b   Milker Zabel, Stefanie ^a   Huber, Peter ^a   Schulz Ertner, Daniela ^a   Schlegel, Wolfgang ^a   Wannenmacher, Michael ^a   Debus, Jürgen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b INF 280   (Germany)

Author keywords

Chemodectoma; Fractionated stereotactic radiotherapy; Glomus tumor; Local control; Paraganglioma; Radiosurgery; Survival

Indexed keywords

DISEASES; FRACTIONATION; NEUROLOGY; PATIENT MONITORING;

CHEMODECTOMAS; SKULL BASE;

RADIOTHERAPY;

ABSCESS; ADULT; AGED; ARTICLE; BALANCE DISORDER; CANCER SURVIVAL; CHEMODECTOMA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CRANIAL NEUROPATHY; DISEASE EXACERBATION; FEMALE; FOLLOW UP; FRACTIONATION; GAMMA IRRADIATION; HEARING LOSS; HUMAN; MALE; MAXILLA; NEUROLOGIC DISEASE; PATIENT SELECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RECURRENT DISEASE; SKULL BASE; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE; SURVIVAL RATE; SYMPTOM; TINNITUS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARAGANGLIOMA, EXTRA-ADRENAL; RADIOTHERAPY, CONFORMAL; SKULL BASE NEOPLASMS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1842424412     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.09.070     Document Type: Article

References (29)

1. Konefal J.B., Pilepich M.V., Spector G.J.H., et al. Radiation therapy in the treatment of chemodectomas. Laryngoscope. 97:1987;1331-1335.
2. Watkins L.D., Mendoza N., Cheesman A.D., et al. Glomus jugulare tumors A review of 61 cases. Acta Neurochir (Wien). 130:1994;66-70.
3. Poe D.S., Jackson C.G., Glasscock M.E., et al. Long-term results after lateral cranial base surgery. Laryngoscope. 101:1991;372-378.
4. Marzo S.J., Leonetti J.P. Current management of glomus jugulare tumors. Neurosurg Q. 7:1997;103-109.
5. Jordan J.A., Roland P.S., McManus C., et al. Stereotactic radiosurgery for chemodectomas. Laryngoscope. 110:2000;35-38.
6. Foote R.L., Pollock B.E., Gorman D.A., et al. Glomus jugulare tumor Tumor control and complications after stereotactic radiosurgery. Head Neck. 24:2002;332-339.
7. Powell S., Peters N., Harmer C. Chemodectoma of the head and neck Results of treatment in 84 patients. Int J Radiat Oncol Biol Phys. 22:1992;919-924.
8. Mumber M.P., Greven K.M. Control of advanced chemodectomas of the head and neck with irradiation. Am J Clin Oncol. 18:1995;389-391.
9. McCabe B., Fletcher M. Selection of therapy of chemodectomas. Arch Otolaryngol. 89:1969;182-185.
10. Debus J., Engenhart-Cabillic R., Knopp M.V., et al. Bildorientierte Planung minimal-invasiver konformierender Bestrahlungsverfahren im Kopf-Hals-Bereich. Radiologe. 36:1996;732-736.
11. Hoess A., Debus J., Bendl R., et al. Computerverfahren in der dreidimensionalen Strahlentherapieplanung. Radiologe. 35:1995;583-586.
12. Gademann G., Schlegel W., Debus J., et al. Fractionated stereotactic guided radiotherapy of head and neck tumors A report on clinical use of a new system in 915 cases. Radiother Oncol. 29:1993;205-213.
13. Guild S.R. The glomus jugulare, a nonchromaffin paraganglion, in man. Ann Otol Rhinol Laryngol. 62:1953;1045-1071.
14. Powell S., Peters N., Harmer C. Chemodectoma of the head and neck Results of treatment in 84 patients. Int Radiat Oncol Biol Phys. 22:1991;919-924.
15. Cummings B.J., Beale F.A., Garrett P.G., et al. The treatment of glomus tumors in the temporal bone by megavoltage radiation. Cancer. 53:1984;2635-2640.
16. Baum U., Greess H., Lell M., et al. Imaging of head and neck tumors - Methods CT, spiral-CT, multislice-spiral-CT. Eur J Radiol. 33:2000;153-160.
17. Mafee M.F., Raofi B., Kumar A., et al. Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions - Role of MR imaging. Radiol Clin North Am. 38:2000;1059-1076.
18. Som P.M., Braun I.F., Shapiro M.D., et al. Tumors of the parapharyngeal space and upper neck MR imaging characteristics. Radiology. 164:1987;823-829.
19. Elshaikh M.A., Mahmoud-Ahmed A.S., Kinney S.E., et al. Recurrent head-and-neck chemodectomas A comparison of surgical and radiotherapeutic results. Int J Radiat Oncol Biol Phys. 52:2002;953-956.
20. Springate S.C., Weichelbaum R.R. Radiation or surgery for chemodectomas of the temporal bone A review of local control and complications. Head Neck. 12:1990;303-307.
21. Kim J.A., Elkon D., Lim M.L., et al. Optimum dose of radiotherapy for chemodectomas of the middle ear. Int J Radiat Oncol Biol Phys. 6:1980;815-819.
22. Cole J.M. Chemodectomas. Laryngoscope. 87:1977;1244-1257.
23. Roa W.H.Y., Hazuka M.B., Sandler H.M., et al. Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses. Int J Radiat Oncol Biol Phys. 28:1994;857-865.
24. Zabel A., Thilmann C., Milker-Zabel S., et al. The role of stereotactically guided conformal radiotherapy for local tumor control of esthesioneuroblastoma. Strahlenther Onkol. 178:2002;187-191.
25. Anand V.K., Leonetti J.P., al-Mefty O. Neurovascular considerations in surgery of glomus tumors with intracranial extensions. Laryngoscope. 103:1993;722-728.
26. Marks L.B. Conventional fractionated radiation therapy vs. radiosurgery for selected benign intracranial lesions (arterious malformations, pituitary adenomas, and acoustic neuromas). J Neurooncol. 17:1993;223-230.
27. Debus J., Kocagöncü K.O., Höss A., et al. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys. 44:1999;243-248.
28. Zabel A., Debus J., Thilmann C., et al. Management of benign cranial nonacoustic schwannomas by fractionated stereotactic radiotherapy. Int J Cancer (Radiat Oncol Invest). 96:2001;356-362.
29. Debus J., Haberer T., Schulz-Ertner D., et al. Bestrahlung von Schädelbasistumoren mit Kohlenstoffionen bei der GSI. Erste klinische Ergebnisse und künftige Perspektiven. Strahlenther Onkol. 176:2000;211-216.